Steven C. Miller Named Chief Commercialization Officer at Senior Scientific Subsidiary of MHTX
August 28, 2012
ALBUQUERQUE, N.M.--Manhattan Scientifics (OTCBB: MHTX) announced today that its Senior Scientific subsidiary has named Steven C. Miller, Ph.D. to the position of Chief Commercialization Officer. Senior Scientific is developing and commercializing technology developed by Dr. Edward R. Flynn. Senior Scientifics’ nanotechnology and imaging technology can detect tumors and metastases much earlier than currently possible and [...]
Idaho Technology, Inc. Becomes BioFire Diagnostics, Inc.™
August 28, 2012
SALT LAKE CITY, - Idaho Technology, Inc., today announced it has changed the corporate name to BioFire Diagnostics, Inc. to more accurately reflect its business strategy and strong momentum in the marketplace. The Company has also re-launched its website (www.BioFireDx.com) to reveal its new branding. "We are excited to announce our new name to our [...]
Changes to the Roche Corporate Executive Committee
August 28, 2012
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Daniel O’Day, currently Chief Operating Officer (COO) of Roche Diagnostics has been appointed as COO of Roche Pharma effective September 1, 2012. He will succeed Pascal Soriot, who will leave Roche and take on new responsibilities outside the Group. Daniel O’Day will be succeeded by Roland [...]
August 28, 2012
SAN DIEGO, -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced that its wholly-owned subsidiary, the Sequenom Center for Molecular Medicine (Sequenom CMM), has completed several international distribution agreements that will expand access to the MaterniT21 PLUS testing service outside the United States. Agreements in [...]
SeraCare Expands HCV and HTLV Performance Panel Offerings
August 28, 2012
Milford, Mass., – SeraCare Life Sciences, a global life sciences company providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics, has expanded its performance panel product offerings. SeraCare’s third Worldwide HCV RNA Performance Panel and eighth Anti-HTLV I/II Mixed Titer Performance Panel are the latest additions to [...]
LGC is using Nanoparticle Tracking Analysis to characterize novel nanoscale reference materials.
August 28, 2012
Salisbury, UK,: NanoSight, leading manufacturers of unique nanoparticle characterization technology, reports on the work of Principal Scientist Dr Damian Marshall and his colleagues at LGC as they develop new methods for characterizing new nanoscale reference materials. LGC is the UK's designated National Measurement Institute for chemical and bioanalytical measurement, the National Reference Laboratory for a [...]
August 28, 2012
WALTHAM, Mass. – PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that it has entered into a collaboration with Dr. John Iafrate and Dr. Long Le of the Massachusetts General Hospital (MGH) Pathology Department and Cancer Center to develop a sequencing informatics system for [...]
August 28, 2012
Biotage® (STO: BIOT), a leading global supplier of solutions and technology for analytical and medicinal chemistry, introduced EVOLUTE® EXPRESS, a novel family of 96-well plates that simplify polymer-based SPE by employing a streamlined 3-step protocol; Load-Wash-Elute. By using this novel approach and removing the conditioning and equilibration steps, necessary with traditional bio-analytical SPE procedures, processing [...]
BioTime Obtains Expanded License to HyStemR Technology
August 27, 2012
ALAMEDA, Calif -- BioTime, Inc. (NYSE MKT:BTX) announced that the company has amended its license from the University of Utah to expand the field of use for which BioTime is licensed to produce and market products covered by the core patents underlying HyStemR technology. Under the amended license, BioTime now is licensed worldwide for all [...]
BD Acquires Sirigen Group Limited
August 27, 2012
FRANKLIN LAKES, N.J., -- BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that it has acquired Sirigen Group Limited, a developer of unique polymer dyes that are used in flow cytometry and can be applied to other technologies. Sirigen's polymer technology is based on Nobel Prize-winning research in conductive plastics [...]
